Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Arquivos Brasileiros de Cardiologia, 109, 5, S. 448-456
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg, GN1 Genesis Network
- (wann)
-
2017
- Urheber
-
Barroso, Michael Coll
Boehme, Philip
Kramer, Frank
Mondritzki, Thomas
Koehler, Till
Gülker, Jan-Erik
Karoff, Martin
Dinh, Wilfried
- DOI
-
10.5935/abc.20170144
- URN
-
urn:nbn:de:bvb:384-opus4-451359
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barroso, Michael Coll
- Boehme, Philip
- Kramer, Frank
- Mondritzki, Thomas
- Koehler, Till
- Gülker, Jan-Erik
- Karoff, Martin
- Dinh, Wilfried
- Universität Augsburg, GN1 Genesis Network
Entstanden
- 2017
Ähnliche Objekte (12)
Evaluation of mouse models of heart failure with preserved ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Histone deacetylase 4 regulates heart failure with preserved ejection fraction through its enzymatic domain
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Histone deacetylase 4 regulates heart failure with preserved ejection fraction through its enzymatic domain
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Histone deacetylase 4 regulates heart failure with preserved ejection fraction through its enzymatic domain
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population